Skip to content
Triangle logo TriangleGet started
← Full study record

NCT03792633 · OUTCOME

Overall Remission Rate (Cohort B)

Study of huCART19 for Very High-Risk (VHR) Subsets of Pediatric B-ALL · Source last updated 2025-06-05

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
28 Days

What was measured

Number of subjects with CR/CRi with B Cell Aplasia at Day 28

Analysis population: Only subjects in cohort B analyzed in this measurement

Groups in this outcome

Cohort B

Patients with poor response to prior B cell directed engineered cell therapy

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Cohort B48

Reported measurements

Source class 1
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Cohort B37Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        37
denoms
  1. counts
    1. group Id
      OG000
      value
      48
    units
    Participants
description
Number of subjects with CR/CRi with B Cell Aplasia at Day 28
groups
  1. description
    Patients with poor response to prior B cell directed engineered cell therapy
    id
    OG000
    title
    Cohort B
param Type
COUNT_OF_PARTICIPANTS
population Description
Only subjects in cohort B analyzed in this measurement
reporting Status
POSTED
time Frame
28 Days
title
Overall Remission Rate (Cohort B)
type
SECONDARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice